IO Biotech, Inc. - Common Stock, par value $0.001 per share (IOBT)

31 filings reported holding IOBT - IO Biotech, Inc. - Common Stock, par value $0.001 per share as of Q4 2024.
IO Biotech, Inc. - Common Stock, par value $0.001 per share (IOBT) has 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 19.7M shares of 68.2M outstanding shares and own 28.86% of the company stock.
Largest 10 shareholders include Vivo Capital, LLC (6.17M shares), Novo Holdings A/S (3.35M shares), PFM Health Sciences, LP (2.34M shares), MARSHALL WACE, LLP (2.11M shares), BANK OF AMERICA CORP /DE/ (1.65M shares), Pivotal bioVenture Partners Investment Advisor LLC (864K shares), MORGAN STANLEY (859K shares), Dauntless Investment Group, LLC (748K shares), LANDSCAPE CAPITAL MANAGEMENT, L.L.C. (442K shares), and CITADEL ADVISORS LLC (271K shares).
This table shows the top 26 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.